•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Compass Group PLC (CMPGY) Q3 2026 Sales/Trading Call Transcript
Compass Group Q3 Earnings Call Highlights
Compass, Inc. to Announce Second Quarter Results on August 4
Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
Top FTSE 100 Index shares to watch next week: Airtel, BT Group, Compass Group
Compass Minerals Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
ADW Capital Management Sends Letter to Compass Diversified's Board Reiterating its Call for an Immediate Strategic Review Process and Orderly Liquidation of the Company
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity
Compass Minerals: Why This Turnaround Is Different
Compass Minerals: Why I Think The Market Is Mispricing The Recovery
Compass Diversified Announces Amendments to Management Services Agreement Reducing Management Costs and Further Strengthening Shareholder Alignment
Compass Pathways Eyes 2027 Launch as Psilocybin Depression Data Holds Up
Compass Pathways: 'Strong Buy' COMP360 Trial Wins And Q4 NDA Full Submission
Compass Pathways Highlights Long-Term Data from Resistant Depression, Backs 2027 Launch Timeline
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Diversified Declares Second Quarter 2026 Distributions on Series A, B and C Preferred Shares
Compass Minerals Announces S&P Global Ratings Upgrade to B+